Cardiovascular Risk Factors in Outpatients with Bipolar Disorder

Background: The mortality due to cardiovascular diseases in bipolar patients is much higher than in the general population. It is unclear whether lithium treatment contributes to this cardiovascular morbidity. Methods: The cardiovascular risk factors in outpatients with bipolar disorder on monotherapy lithium were explored. Cardiac (family) history, important habits and recent stressful events were assessed. Quetelet Index (QI) was calculated and blood samples were taken. Blood pressure (BP) was measured in supine position and during orthostatic challenge. Results: 40 out of 81 patients on monotherapy lithium were studied in detail. In this group, one patient was hypothyroid; six patients suffered from hypertension. QI was > 25 in 57.5 % of the patients; mean cholesterol level was 5.7 mmol/L. Renal functioning, electrolytes and glucose concentrations were normal. There were no significant relationships between the duration of lithium treatment, the duration of bipolar disorder, recent stressful events and hypertension. Out of the group of 81 patients on lithium monotherapy, 13 patients in total used antihypertensive medication, indicating a high prevalence of hypertension in this group as compared to the general population. Conclusions: Cardiovascular risk factors, including hypertension, were increased in a large proportion of this population on monotherapy lithium. However, no significant relationships were observed between duration of lithium treatment or bipolar disorder and presence of hypertension.

References

• 1 Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E ,. et al . Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis.  J Affect Disord. 1995;  33 67-75
• 2 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (4th ed.) Washington; American Psychiatric Association 1994
• 3 American Psychiatric A ssociation. Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision).  Am J Psychiatry. 2002;  159(suppl) 1-50
• 4 Angst F, Stassen H H, Clayton P J, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years.  J Affect Disord. 2002;  68 167-81
• 5 Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders (Cochrane Methodology Review).  In: The Cochrane Library. Chichester, UK; John Wiley & Sons, Ltd 2003 Issue 4
• 6 Gershon E S, Hamovit J, Guroff J J, Dibble E, Leckman J F, Sceery W ,. et al . A family study of schizo-affective, bipolar I, bipolar II, unipolar, and normal control probands.  Arch Gen Psychiatry. 1982;  39 1157-1167
• 7 Grobbee D E, Tuut M K, Hoes A W. CBO-richtlijn ”Hoge Bloeddruk” herziening.  Ned Tijdschr Geneeskd. 2001;  145 2071-2076
• 8 Haustein K O, Haffner S, Woodcock B G. A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients.  Int J Clin Pharmacol Ther. 2002;  40 404-418
• 9 Hayward C. Psychiatric illness and cardiovascular disease risk.  Epidemiol Rev. 1995;  17 129-138
• 10 Hofman A, Valkenburg H A. Een epidemiologisch onderzoek naar risico-indicatoren voor hart- en vaatziekten (EPOZ). II. Voorkomen, opsporing en behandeling van hypertensie in een open bevolking.  Ned Tijdschr Geneeskd. 1980;  124 189-195
• 11 Johnson F N. Depression & Mania; modern lithium therapy. Oxford; IRL Press Limited 1987
• 12 Johnson F N. Lithium and the endocrine system. Basel; Karger 1988
• 13 Kaplan H I, Sadock B J. Comprehensive textbook of psychiatry/VI. Baltimore; Williams & Wilkins 1995
• 14 Kirov G. Thyroid disorders in lithium-treated patients.  J Affect Disord. 1998;  50 33-40
• 15 Kleiner J, Altshuler L, Hendrick V, Hershman J M. Lithium-induced subclinical hypothyroidism: Review of the literature and guidelines for treatment.  J Clin Psychiatry. 1999;  60 249-255
• 16 Kuulaasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H ,. et al . Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.  Lancet. 2000;  355 675-687
• 17 Laragh J H, Brenner B M. Hypertension; pathophysiology, diagnosis and management. New York; Raven Press 1995
• 18 Loonen A JM, Doorschot C H, Jogems-Kosterman B JM, Van Hoof J JM, Hulstijn W, Zitman F G. Nieuw instrumentarium voor het meten van bijwerkingen.  COBO Bulletin. 1997;  30 31-40
• 19 Loonen A JM, Doorschot C H, van Rooij W PA, Wolffenbuttel A LM. MAESEAS-computerinterview. ‘s-Hertogenbosch 1995
• 20 Loonen A JM, Nolen W A. Antipsychotica en antidepressiva. In: H. Wesseling, C. Neef, PA de Graeff, editors Algemene farmacotherapie. 7e druk. Houten; Bohn Stafleu Van Loghum 1999: pp 165-194
• 21 Mackay C J. The measurement of mood and psychophysiological activity using self-report techniques. Techniques in psychophysiology. John Wiley & Sons Ltd 1980
• 22 Mathus-Vliegen E MH. Overgewicht. I. Prevalenties en trends.  Ned Tijdschr Geneeskd. 1998;  142 1983-1988
• 23 Michaeli J, Ben-Ishay D, Kidron R, Dasberg H. Severe hypertension and lithium intoxication.  JAMA. 1984;  251 1680
• 24 Moeller H -J, Nasrallah H A. Treatment of Bipolar Disorder.  J Clin Psychiatry. 2003;  64(suppl 6) 9-17
• 25 Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden.  Arch Gen Psychiatry. 2001;  58 844-850
• 26 Roelandt J RTC, Lie K I, Wellens H JJ, Van de Werf F. Leerboek cardiologie. Houten/Diegen. Bohn Stafleu van Loghum 1995
• 27 Van de Lisdonk E H, van den Bosch W JHM, Huygen F JA, Lagro-Janssen A LM. Ziekten in de huisartspraktijk. Utrecht; Wetenschappelijke Uitgeverij Bunge 1994: pp 166-169
• 28 Van de Voort L MP. Onderzoeksverslag wetenschappelijke stage: Exploratief onderzoek naar de validiteit en betrouwbaarheid van het MASEAS-computerinterview bij antidepressivum- en antipsychoticumgebruikers. 1997
• 29 Vanderpump M P, Tunbridge W M. Epidemiology and prevention of clinical and subclinical hypothyroidism.  Thyroid. 2002;  10 839-847
• 30 Yates W R, Wallace R. Cardiovascular risks factors in affective disorder.  J Affect Disord. 1987;  12 129-134